Torisel, Sutent, Nexavar Combinations Are “Future” Of RCC Treatment – Wyeth Exec
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth plans to look at drug combinations in the kidney cancer arena using its renal cell carcinoma candidate Torisel.